文献速递血液净化与透析水电解质与酸碱

血液透析患者血清钾与短期临床结局:长透析间期的影响

Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval.
PubMed 文献 · Am J Kidney Dis · 2017-01-19

该回顾性观察研究纳入2010至2011年一家大型透析机构52,734例中心血液透析患者的533,889次血钾测量,发现血钾升高与短期住院、急诊就诊和死亡风险增加相关;血钾与住院风险的关联受星期几修饰,周五(长透析间期后)关联更强,调整OR为1.68(95%CI 1.22-2.30)。

要点

  • 血钾5.5至<6.0 mEq/L(参照4.0-<4.5 mEq/L)与周五住院风险增加相关,调整OR 1.68(95%CI 1.22-2.30)。
  • 血钾5.5至<6.0 mEq/L在周一仅轻度增加住院风险(调整OR 1.12,95%CI 1.00-1.24),周三无显著增加(调整OR 1.04,95%CI 0.94-1.16)。
  • 血钾6.0-<6.5 mEq/L或更高与死亡和急诊就诊风险显著相关,但不因星期几而异。

核心结论

  • 较高的血清钾与短期住院、急诊就诊和死亡风险增加相关;血清钾与住院风险的关联受星期几修饰,与长透析间期后钾蓄积促成不良结局一致。
  • 需要进一步研究确定针对性干预是否能改善这一风险。

研究设计与样本

  • 回顾性观察研究,纳入2010至2011年一家大型透析机构接受中心血液透析的52,734例患者,贡献533,889次血钾测量(周一230,634次;周三285,522次;周五17,733次)。

主要发现

  • 较高的血清钾与96小时内住院风险显著相关,且周五(389例住院)的关联幅度大于周一或周三(分别为4,582例和4,629例住院;交互作用P=0.008)。
  • 血钾5.5至<6.0 mEq/L(参照4.0-<4.5 mEq/L)与周五住院风险增加相关,调整OR为1.68(95%CI 1.22-2.30)。
  • 血钾5.5至<6.0 mEq/L在周一仅轻度增加住院风险(调整OR 1.12,95%CI 1.00-1.24),周三无显著增加(调整OR 1.04,95%CI 0.94-1.16)。
  • 血钾6.0-<6.5 mEq/L或更高与死亡和急诊就诊的关联显著,但不因星期几而异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 观察数量不足以检测星期几对死亡、急诊就诊和特定住院原因的效应修饰。
  • 混杂可能影响了结果。
  • 需要进一步研究确定针对性干预是否能改善这一风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperkalemia is common among hemodialysis patients and is associated with morbidity and mortality. The long interdialytic interval is likewise associated with adverse outcomes. However, the interplay among serum potassium, dialysis cycle phase, and clinical outcomes has not been examined. STUDY DESIGN: Retrospective observational study. SETTING & PARTICIPANTS: 52,734 patients receiving in-center hemodialysis at a large dialysis organization during 2010 and 2011 contributed 533,889 potassium measurements (230,634 on Monday; 285,522 on Wednesday; 17,733 on Friday). PREDICTOR: Serum potassium concentration, day of the week of potassium measurement. OUTCOMES: Death, hospitalization, emergency department (ED) visit. RESULTS: There was a significant association between higher serum potassium and risk of hospitalization within 96 hours that was of greater magnitude on Fridays (389 hospitalizations) than Mondays or Wednesdays (4,582 and 4,629 hospitalizations, respectively; P for interaction = 0.008). Serum potassium of 5.5 to <6.0 (vs the referent category of 4.0-<4.5 mEq/L) was associated with increased risk of hospitalization on Fridays, with an adjusted OR of 1.68 (95% CI, 1.22-2.30). However, serum potassium of 5.5 to <6.0 mEq/L was associated with only mild elevation of risk on Mondays and no significantly increased risk on Wednesdays (adjusted ORs of 1.12 [95% CI, 1.00-1.24] and 1.04 [95% CI, 0.94-1.16], respectively). Associations of elevated serum potassium (6.0-<6.5 mEq/L or greater) with death and ED visit were significant, but did not differ based on day of the week. LIMITATIONS: There were insufficient observations to detect effect modification by day of the week for deaths, ED visits, and specific causes of hospitalizations. Confounding may have influenced results. CONCLUSIONS: Higher serum potassium is associated with increased short-term risk of hospitalization, ED visit, and death. The association between serum potassium and hospitalization risk is modified by day of the week, consistent with a contribution of accumulated potassium to adverse outcomes following the long interdialytic interval. Further work is needed to determine whether directed interventions ameliorate this risk.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Brunelli SM, Du Mond C, Oestreicher N, et al. Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval. Am J Kidney Dis. 2017. PMID: 28111027. doi:10.1053/j.ajkd.2016.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。